Category: Disease States

Disease States

Blood Test ‘Clock’ Predicts Alzheimer’s Symptom Onset Within Years

Washington University researchers have developed a blood test using p-tau217 protein levels to predict Alzheimer’s symptom onset within three to four years.

Disease States

Fecal DNA Methylation Test Shows Promise for Colorectal Cancer Screening

A multicenter study reports that combining fecal SDC2 methylation testing with the APCS scoring system improves advanced adenoma detection and specificity in colorectal cancer screening.

Disease States

Blood Test Shows Obesity Speeds Alzheimer’s Development

A longitudinal study finds blood-based biomarkers more sensitive than PET scans in detecting obesity's impact on Alzheimer's pathology.

Cancer

Personalis Receives Medicare Coverage for NeXT Personal in Lung Cancer Surveillance

The NeXT Personal molecular residual disease test can now be used for surveillance of patients with Stage I to III non-small cell lung cancer.

Infectious Diseases

CDC Selects Cepheid as National Collaborator for Rapid Diagnostic Development

The CDC has named Cepheid one of four national collaborators to accelerate rapid diagnostic assay development for public health emergencies under a new federal initiative and IDIQ contract.

Womens Health

FDA Approves PD-L1 Test to Guide Immunotherapy in Ovarian and Related Cancers

PD-L1 testing is now cleared to help identify patients with epithelial ovarian, fallopian tube, or primary peritoneal carcinoma who may be eligible for anti–PD-1 therapy.

Allergy & Autoimmune

New Gene Expression Test Helps Guide Atopic Dermatitis Treatment Decisions

Castle Biosciences' AdvanceAD-Tx test identifies patients more likely to respond to JAK inhibitor therapy versus Th2-targeted treatments.

Cardiovascular, Cerebrovascular

New Urine Test Offers Faster, Cheaper Diagnosis for Inherited Nerve Disorder

The test measures two sugar alcohols to detect SORD-related neuropathy, which standard genetic tests sometimes miss.

Dementias & Alzheimer’s

Quanterix Submits FDA 510(k) for Multi-Analyte Alzheimer’s Blood Test

The test uses five biomarkers and proprietary technology to detect amyloid brain plaques in patients with cognitive symptoms.

Diabetes & Metabolic Diseases

BetterWay Expands GLP-1 Blood Testing Panel to Texas Retail Locations

Babson Diagnostics’ BetterWay GLP-1 blood testing panel is now available at more than 25 Austin and Temple, Texas, retail locations, including Sam’s Club and Peoples Rx pharmacies. The panel features 29 tests to support GLP-1 therapy.

Kidney Disease

Carna Health, Siemens Healthineers Partner on AI-Enabled CKD Platform

The agreement aims to improve early detection and management of chronic kidney disease in underserved populations through integrated diagnostics and digital health solutions.

Respiratory Disease

Yourgene Health Cystic Fibrosis Assay Receives IVDR Accreditation

The Cystic Fibrosis Base assay has received IVDR accreditation, ensuring high standards for detecting cystic fibrosis mutations.

Sepsis

Rapid Sepsis Test Reduces Mortality by 42% in Academic Medical Center Study

The eight-minute test also shortened hospital stays by nearly two days at Froedtert Hospital, reinforcing previous multi-site evidence.